Controlled study to investigate management methods of gout attack for gout patients with uric-acid lowering therapy

Trial Profile

Controlled study to investigate management methods of gout attack for gout patients with uric-acid lowering therapy

Completed
Phase of Trial: Phase III

Latest Information Update: 04 Nov 2017

At a glance

  • Drugs Febuxostat (Primary) ; Colchicine
  • Indications Gout
  • Focus Therapeutic Use
  • Acronyms FORTUNE-1
  • Most Recent Events

    • 04 Nov 2017 Primary endpoint (Incidence rate of gout attack during the treatment period) has not been met as per the results published in the Annals of the Rheumatic Diseases
    • 04 Nov 2017 Results published in the Annals of the Rheumatic Diseases
    • 26 May 2015 Status changed from active, no longer recruiting to completed, according to University Hospital Medical Information Network - Japan record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top